AEON – aeon biopharma, inc. class a (US:NASDAQ)
Stock Stats
News
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
AEON Biopharma, Inc. (NASDAQ: AEON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting
Form SC 13G AEON Biopharma, Inc. Filed by: Blue Owl Capital Holdings LP
Form 424B3 AEON Biopharma, Inc.
Form 10-Q AEON Biopharma, Inc. For: Sep 30
Form 8-K AEON Biopharma, Inc. For: Nov 13
Form 8-K AEON Biopharma, Inc. For: Oct 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.